Malignant neoplasm of breast
|
0.330 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Alzheimer's Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Northern blot analysis indicated that PN-1 mRNA levels were about equal in brains from AD patients and control individuals.
|
2813392 |
1989 |
Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Added PN-1 bound to the surface of both glioblastoma and neuroblastoma cells.
|
1987320 |
1991 |
Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Added PN-1 bound to the surface of both glioblastoma and neuroblastoma cells.
|
1987320 |
1991 |
Adult Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Added PN-1 bound to the surface of both glioblastoma and neuroblastoma cells.
|
1987320 |
1991 |
Childhood Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Added PN-1 bound to the surface of both glioblastoma and neuroblastoma cells.
|
1987320 |
1991 |
Central neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Added PN-1 bound to the surface of both glioblastoma and neuroblastoma cells.
|
1987320 |
1991 |
Glioblastoma Multiforme
|
0.010 |
Biomarker
|
disease |
BEFREE |
Added PN-1 bound to the surface of both glioblastoma and neuroblastoma cells.
|
1987320 |
1991 |
Childhood Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Added PN-1 bound to the surface of both glioblastoma and neuroblastoma cells.
|
1987320 |
1991 |
Reperfusion Injury
|
0.200 |
Biomarker
|
disease |
RGD |
The glia-derived protease nexin 1 persists for over 1 year in rat brain areas selectively lesioned by transient global ischaemia.
|
8261109 |
1993 |
Systemic Scleroderma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Western analysis showed that scleroderma fibroblasts also secreted more PN1.
|
10207170 |
1999 |
Scleroderma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Western analysis showed that scleroderma fibroblasts also secreted more PN1.
|
10207170 |
1999 |
Astrocytoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Expression of six genes (TIMP3, c-myc, EGFR, DR-nm23, nm23-H4, and GDNPF) was detected in 64-100% of diffuse astrocytomas, but not in nontumorous brain tissue.
|
11156382 |
2000 |
Astrocytoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
We have examined expression of the components of the plasminogen activation system in human astrocytoma U373-MG cells and found that interleukin 1beta (IL-1beta), tumour necrosis factor alpha TNF-alpha), interferon gamma (INF-gamma) and epidermal growth factor (EGF) specifically regulate the expression of tissue-type plasminogen activator (t-PA), urokinase-type plasminogen activator (u-PA), plasminogen activator inhibitor type 1 (PAI-1) and protease nexin-1 (PN-1).
|
11814314 |
2001 |
Childhood Astrocytoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We have examined expression of the components of the plasminogen activation system in human astrocytoma U373-MG cells and found that interleukin 1beta (IL-1beta), tumour necrosis factor alpha TNF-alpha), interferon gamma (INF-gamma) and epidermal growth factor (EGF) specifically regulate the expression of tissue-type plasminogen activator (t-PA), urokinase-type plasminogen activator (u-PA), plasminogen activator inhibitor type 1 (PAI-1) and protease nexin-1 (PN-1).
|
11814314 |
2001 |
Systemic Scleroderma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
PN-1 messenger levels were not significantly altered by IFNbeta treatment in normal or SSc cultured fibroblasts despite the presence of an IFN-stimulated responsive element (ISRE) in the promoter of the PN-1 gene.
|
11876527 |
2002 |
Hepatitis B
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Slot blots result showed a 8-fold increase of glia-derived nexin/protease nexin 1 (GDN/PN1) gene expression level and 4-fold increase of hepatitis B virus x-interacting protein (XIP) mRNA level in BGC823 cells after Allitridi treatment for 72h.
|
11925594 |
2002 |
Hypertensive disease
|
0.200 |
Biomarker
|
group |
RGD |
Marked increases in PN-1 mRNA (3-fold) and protein (2-fold) were observed after 2 months of hypertension.
|
12524238 |
2003 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Although overall metastatic activity of the transfected cells in vivo was also unaltered, SERPINE2 overexpression greatly enhanced the local invasiveness of the s.c. xenograft tumors, accompanied by a massive increase in extracellular matrix (ECM) production in the invasive tumors.
|
12941819 |
2003 |
Neoplasm Metastasis
|
0.080 |
Biomarker
|
phenotype |
BEFREE |
One of the genes most strongly overrepresented in the highly metastatic subclone S2-007 as compared with the rarely metastatic subclone S2-028 was the serine proteinase inhibitor SERPINE2 (protease nexin I), suggesting that this protein may play an important part in the process of metastasis.
|
12941819 |
2003 |
Tumor Cell Invasion
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo.
|
12941819 |
2003 |
Cerebral Infarction
|
0.010 |
GeneticVariation
|
disease |
LHGDN |
Prothrombotic gene polymorphisms and atherothrombotic cerebral infarction.
|
12859287 |
2003 |
Pancreatic Neoplasm
|
0.010 |
Biomarker
|
disease |
BEFREE |
SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo.
|
12941819 |
2003 |
Chronic Obstructive Airway Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
After the integration of murine and human microarray data to inform candidate-gene selection, we observed significant family-based association and independent replication of association in a case-control study, suggesting that SERPINE2 is a COPD-susceptibility gene and is likely influenced by gene-by-smoking interaction.
|
16358219 |
2006 |
Infectious Mononucleosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Oligonucleotide microarrays were used to examine PNI gene expression in the peripheral blood of 13 subjects with infectious mononucleosis (IM).
|
16376318 |
2006 |